number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic avapro 150 mg side effects on skin life 11–15.

number 138402-11-6ATC avapro 150 mg side effects on skin C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules avapro 150 mg side effects on skin PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis avapro 150 mg side effects on skin Bristol-Myers Squibb under avapro 150 mg side effects on skin trade names Aprovel, Karvea, and Avapro.Contents [hide]1 Clinical use1.1 Indications1.2 Combination with avapro 150 mg side effects on skin References3 See also[edit] Clinical useMain article: Angiotensin II receptor antagonists, avapro 150 mg side effects on skin is indicated for the treatment of hypertension. Irbesartan was developed by Sanofi Research avapro 150 mg side effects on skin part of sanofi-aventis). It is jointly.

(U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonist used.